Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats

Diabetes

Volumn 61, Issue 4, 2012, Pages 925-932

  Hashikawa Hobara, Narumi ^a   Hashikawa, Naoya ^a   Inoue, Yusuke ^a   Sanda, Hitomi ^a   Zamami, Yoshito ^b   Takatori, Shingo ^b   Kawasaki, Hiromu ^b  

^a OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CANDESARTAN HEXETIL; FRUCTOSE; INSULIN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CELL ELONGATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HOT PLATE TEST; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MESENTERIC ARTERY; NERVE FIBER GROWTH; NOCICEPTION; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; SENSORY NERVE; SIGNAL TRANSDUCTION; SPINAL GANGLION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; FRUCTOSE; GENE EXPRESSION REGULATION; INSULIN; INSULIN RESISTANCE; NEURITES; NOCICEPTION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; TETRAZOLES;

EID: 84859529833     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1468     Document Type: Article

References (30)

1. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 1997;100:2158-2169 (Pubitemid 27500137)
2. Shiuchi T, Iwai M, Li HS, et al. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 2004;43:1003-1010 (Pubitemid 38579905)
3. Wei Y, Sowers JR, Nistala R, et al. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 2006;281:35137-35146 (Pubitemid 46036553)
4. Igarashi M, Hirata A, Nozaki H, Kadomoto-Antsuki Y, Tominaga M. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats. Diabetes Res Clin Pract 2007;75:267-277 (Pubitemid 46074213)
5. Shanmugam S, Corvol P, Gasc JM. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 1996;28:91-97 (Pubitemid 26231095)
6. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P, Dzau VJ, Pratt RE. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005;112:3328-3336 (Pubitemid 43739379)
7. Stroth U, Meffert S, Gallinat S, Unger T. Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor. Brain Res Mol Brain Res 1998;53:187-195 (Pubitemid 28085454)
8. Takatori S, Zamami Y, Yabumae N, et al. Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia. Br J Pharmacol 2008;153:1388-1398 (Pubitemid 351481528)
9. Zamami Y, Takatori S, Hobara N, et al. Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens Res 2011;34:1190-1196
10. Hobara N, Goda M, Yoshida N, et al. Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries. Neuroscience 2007;150:730-741 (Pubitemid 350198723)
11. Read DE, Gorman AM. Involvement of Akt in neurite outgrowth. Cell Mol Life Sci 2009;66:2975-2984.
12. Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther 1953;107:385-393
13. Zawalich WS, Zawalich KC. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats. Endocrinology 2000;141:3287-3295 (Pubitemid 32269017)
14. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989;49:1155-1163 (Pubitemid 19169675)
15. Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 2005;289:E113-E122 (Pubitemid 40874942)
16. Russell JC, Kelly SE, Vine DF, Proctor SD. Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats. Br J Pharmacol 2009;158:1588-1596
17. Ran J, Hirano T, Adachi M. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab 2004;287:E227-E232 (Pubitemid 38943886)
18. Cui TX, Nakagami H, Nahmias C, et al. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Mol Endocrinol 2002;16:2113-2123 (Pubitemid 35013459)
19. Higashiura K, Ura N, Miyazaki Y, Shimamoto K. Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension. J Hum Hypertens 1999;13(Suppl. 1):S71-S74 (Pubitemid 29057661)
20. Clasen R, Schupp M, Foryst-Ludwig A, et al. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 2005; 46:137-143 (Pubitemid 40946504)
21. Pscherer S, Heemann U, Frank H. Effect of renin-angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance. Diabetes Care 2010;33:914-919
22. Suksomboon N, Poolsup N, Prasit T. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes. J Clin Pharm Ther. 17 August 2011 [Epub ahead of print]
23. Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK. Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 2005;25:1142-1147 (Pubitemid 40776600)
24. Csibi A, Communi D, Müller N, Bottari SP. Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS ONE 2010;5:e10070
25. Zhou MS, Schulman IH, Raij L. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Am J Physiol Heart Circ Physiol 2009;296:H833-H839
26. Kimura K, Hattori S, Kabuyama Y, et al. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3- kinase. J Biol Chem 1994;269:18961-18967
27. Kim Y, Seger R, Suresh Babu CV, Hwang SY, Yoo YS. A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol Cells 2004;18: 353-359 (Pubitemid 40298032)
28. You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 2005;111:1006-1011 (Pubitemid 40354518)
29. Gendron L, Payet MD, Gallo-Payet N. The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. J Mol Endocrinol 2003;31:359-372. (Pubitemid 38054511)
30. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999;286:1741-1744 (Pubitemid 129515882)